Polymorphism in the CCR5 Gene Promoter and HIV-1 Infection in North Indians

Human Immunology

Volumn 68, Issue 5, 2007, Pages 454-461

  Kaur, Gurvinder ^a   Singh, P ^a   Rapthap, C C ^a   Kumar, N ^a   Vajpayee, M ^a   Sharma, S K ^a   Wanchu, A ^b   Mehra, N K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

AIDS; CCR5; Chemokine receptors; HIV 1; polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; GENE DELETION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; HAPLOTYPE; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; GENE DELETION; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INDIA; LYMPHOCYTE COUNT; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RECEPTORS, CCR5;

EID: 34247272367     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.01.016     Document Type: Article

References (37)

1. Arenzana-Seisdedos F., and Parmentier M. Genetics of resistance to HIV infection: role of co-receptors and co-receptor ligands. Semin Immunol 18 (2006) 387
2. Shrestha S., Strathdee S.A., Galai N., Oleksyk T., Fallin M.D., Mehta S., Schaid D., Vlahov D., O'Brien S.J., and Smith M.W. Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J Infect Dis 193 (2006) 16
3. Kaslow R.A., Dorak T., and Tang J.J. Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis. 191 Suppl 1 (2005) S68
4. O'Brien S.J., and Nelson G.W. Human genes that limit AIDS. Nat Genet 36 (2004) 565
5. Smith M.W., Dean M., Carrington M., Winkler C., Huttley G.A., Lomb D.A., Goedert J.J., O'Brien T.R., Jacobson L.P., Kaslow R., Buchbinder S., Vittinghoff E., Vlahov D., Hoots K., Hilgartner M.W., and O'Brien S.J. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277 (1997) 959
6. Kostrikis L.G., Neumann A.U., Thomson B., Korber B.T., McHardy P., Karanicolas R., Deutsch L., Huang Y., Lew J.F., McIntosh K., Pollack H., Borkowsky W., Spiegel H.M., Palumbo P., Oleske J., Bardeguez A., Luzuriaga K., Sullivan J., Wolinsky S.M., Koup R.A., Ho D.D., and Moore J.P. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol 73 (1999) 10264
7. McDermott D.H., Zimmerman P.A., Guignard F., Kleeberger C.A., Leitman S.F., and Murphy P.M. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 352 (1998) 866
8. Martin M.P., Dean M., Smith M.W., Winkler C., Gerrard B., Michael N.L., Lee B., Doms R.W., Margolick J., Buchbinder S., Goldert J.J., O'Brien T.R., Hilgartner M.W., Vlahov D., O'Brien S.J., and Carrington M. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282 (1998) 1907
9. Mummidi S., Bamshad M., Ahuja S.S., Gonzalez E., Feuillet P.M., Begum K., Galvis M.C., Kostecki V., Valente A.J., Murthy K.K., Haro L., Dolan M.J., Allan J.S., and Ahuja S.K. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem 275 (2000) 18946
10. Blanpain C., Lee B., Tackoen M., Puffer B., Boom A., Libert F., Sharron M., Wittamer V., Vassart G., Doms R.W., and Parmentier M. Multiple nonfunctional alleles of CCR5 are frequent in various human populations. Blood 96 (2000) 1638
11. Dean M., Carrington M., and O'Brien S.J. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 3 (2002) 263
12. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbaksh K., Kunstman K., Erickson D., Dragon E., Landau N.R., Phair J., Ho D.D., and Koup R.A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2 (1996) 1240
13. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., and Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86 (1996) 367
14. O'Brien T.R., Winkler C., Dean M., Nelson J.A., Carrington M., Michael N.L., and White G.C.2n. HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 349 (1997) 1219
15. Buseyne F., Janvier G., Teglas J.P., Ivanoff S., Burgard M., Bui E., Mayaux M.J., Blanche S., Rouzioux C., and Riviere Y. Impact of heterozygosity for the chemokine receptor CCR5 32 bp deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus infected children at 8 years of age. J Infect Dis 178 (1998) 1019
16. Zimmerman P.A., Buckler-White A., Alkjatib G., Spalding T., Kubofcik J., Combadiere C., Weissman D., Cohen O., Rubbert A., Lam G., Vaccarzza M., Kennedy P.E., Kumaraswami V., Giorgi J.V., Detels R., Hunter J., Chopek M., Berger E.A., Fauci A.S., Nutman T.B., and Murphy P.M. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 3 (1997) 23
17. Libert F., Cochaux P., Beckman G., Samson M., Aksenova M., Cao A., Czeizel A., Claustres M., de la Rua C., Ferrari M., Ferrec C., Glover G., Grinde B., Guran S., Kucinskas V., Lvinha J., Mercier B., Ogur G., Peltonen L., Rosatelli C., Schwartz M., Spitsyn V., Timar L., Beckman L., Parmentier M., and Vassart G. The deltaCCR5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in North Eastern Europe. Hum Mol Genet 7 (1998) 399
18. Lucotte G., and Mercier G. Distribution of the CCR5 gene 32 bp deletion in Europe. J Acquir Defic Syndr Hum Retrovir 19 (1998) 174
19. Martinson J.J., Chapman N.H., Rees D.C., Liu Y.T., and Clegg J.B. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 16 (1997) 100
20. Mummidi S., Ahuja S.S., McDaniel B.L., and Ahuja S.K. The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5′ end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J Biol Chem 272 (1997) 30662
21. Gonzalez E., Bamshad M., Sato N., Mummidi S., Dhanda R., Catano G., Cabrera S., McBride M., Cao X.H., Merrill G., O'Connell P., Bowden D.W., Freedman B.I., Anderson S.A., Walter E.A., Evans J.S., Stephan K.T., Clark R.A., Tyagi S., Ahuja S.S., Dolan M.J., and Ahuja S.K. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci USA 96 (1999) 12004
22. Singh K.K., Barroga C.F., Hughes M.D., Chen J., Raskino C., McKinney R.E., and Spector S.A. Genetic influence of CCR5, CCR2 and SDF-1 variants on HIV-1 related disease progression and neurological impairment in children with symptomatic HIV-1 infection. J Infect Dis 188 (2003) 1461
23. Tang J., Shelton B., Makhatadze N.J., Zhang Y., Schaen M., Louie L.G., Goedert J.J., Seaberg E.C., Margolick J.B., Mellors J., and Kaslow R.A. Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression. J Virol 76 (2002) 662
24. Ming L., Song R., Masiciotra S., Soriano V., Spira T.J., Lal R.B., and Yang C. Association of CCR5 human haplogroup E with rapid HIV type 1 disease progression. AIDS Res Hum Retrovir 21 (2005) 111
25. Mangano A., Gonzalez E., Dhanda R., Catano G., Bamshad M., Bock A., Duggirala R., Williams K., Mummidi S., Clark R.A., Ahuja S.S., Dolan M.J., Bologna R., Sen L., and Ahuja S.K. Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus. J Infect Dis 183 (2001) 1574
26. Sriwanthana B., Hodge T., Mastro T.D., Dezzutti C.S., Bond K., Stephens H.A., Kostrikis L.G., Limpakarnjanarat K., Young N.L., Qari S.H., Lal R.B., Chandanayingyong D., and McNicholl J.M. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine related factors may act synergistically to determine HIV resistance in CCR5 D32 negative female sex workers in Chiang Rai, northern Thailand. AIDS Res Hum Retrovir 17 (2001) 719
27. Nguyen L., Li M., Chaowanachan T., Hu D.J., Vanichseni S., Mock P.A., van Griensven F., Martin M., Sangkum U., Choopanya K., Tappero J.W., Lal R.B., and Yang C. CCR5 promoter human haplogroups associated with HIV-1 disease progression in Thai injection drug users. AIDS 18 (2004) 1327
28. John G.C., Bird T., Overbaugh J., Nduati R., Mbori-Ngacha D., Rostron T., Dong T., Kostrikis L., Richardson B., and Rowland-Jones S.L. CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2 year maternal mortality. J Infect Dis 184 (2001) 89
29. Kageyama S., Mimaya J., Yamada K., Kurimura T., and Shiraki K. Polymorphism of CCR5 affecting HIV disease progression in the Japanese population. AIDS Res Hum Retrovir 17 (2001) 991
30. Ioannidis J.P., Rosenberg P.S., Goedert J.J., Ashton L.J., Benfield T.L., Buchbinder S.P., Coutinho R.A., Eugen-Olsen J., Gallart T., Katzenstein T.L., Kostrikis L.G., Kuipers H., Louie L.G., Mallal S.A., Margolick J.B., Martinez O.P., Meyer L., Michael N.L., Operskalski E., Pantaleo G., Rizzardi G.P., Schuitemaker H., Sheppard H.W., Stewart G.J., Theodorou I.D., Ullum H., Vicenzi E., Vlahov D., Wilkinson D., Workman C., Zagury J.F., and O'Brien T.R. International Meta-Analysis of HIV Host Genetics. Effects of CCR5-Delta 32, CCR2-64I, and SDF-1 3′A alleles on HIV-1 disease progression: an international meta analysis of individual patient data. Ann Intern Med 135 (2001) 782
31. Bamshad M.J., Mummidi S., Gonzalez E., Ahuja S.S., Dunn D.M., Watkins W.S., Wooding S., Stone A.C., Jorde L.B., Weiss R.B., and Ahuja S.K. A strong signature of balancing selection in the 5′ cis-regulatory region of CCR5. PNAS 99 (2002) 10539
32. McNicholl J.M., Lal R.B., and Kaslow R. Human immunodeficiency virus (HIV) infection: genetics. In: Cooper D.N. (Ed). Encyclopedia of the Human Genome (2003), Nature Publishing Group. http://www.ehgonline.net www.ehgonline.net
33. Vajpayee M., Kaushik S., Sreenivas V., Wig N., and Seth P. CDC staging based on absolute CD4 count and CD4 percentage in an HIV-1 infected Indian population: treatment implications. Clin Exp Immunol 141 (2005) 485
34. Tang J., Rivers C., Karita E., Costello C., Allen S., Fultz P.N., Schoenbaum E.E., and Kaslow R.A. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression. Genes Immunity 1 (1999) 20
35. Kaur G, Rapthap CC, Kumar N, Kumar S, Neolia S, Mehra NK: Frequency distribution of cytokine gene polymorphisms in the healthy North Indian population. Tissue Antigens (in press).
36. Suresh P., Wanchu A., Sachdeva R.K., and Bhatnagar A. Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in North India. J Clin Immunol 26 (2006) 476
37. Majumdar P.P., and Dey B. Absence of the HIV-1 protective ΔCCR5 allele in most ethnic populations of India. Eur J Hum Genet 9 (2001) 794